Pioglitazone on insulin resistance in patients with polycystic ovary syndrome the impact of adipocytokines.docVIP

 PAGE \* MERGEFORMAT 8 Pioglitazone on insulin resistance in patients with polycystic ovary syndrome the impact of adipocytokines [Abstract] Objective To investigate the insulin sensitizer pioglitazone in the treatment of insulin-resistant polycystic ovary syndrome (PCOS) when the adipocytokines leptin, resistin and adiponectin changes. Methods 35 patients with insulin-resistant PCOS were treated with pioglitazone treatment 12 weeks, monitoring before and after treatment in patients with clinical indicators, testing before and after treatment of serum adipocytokines, fasting plasma glu